Michigan Medicine extends the right to systematically vaccinate COVID-19

ANN ARBOR Michigan Medicine announced in an email to staff on Monday that it has expanded the Phase 1A COVID-19 vaccine priority group after administering more than 11,000 vaccines since December 14th.

Based on recommendations from the state, those who are now eligible for a Phase 1A vaccine at the University of Michigan include:

• Anyone who plays a role at Michigan Medicine or University of Michigan who works in a clinical setting (ie hospital, outpatient clinic, home care) and cannot work exclusively remotely can now receive a COVID-19 vaccine as part of phase 1A.
• Anyone serving in a clinical setting at the University of Michigan and unable to work exclusively can also now receive a COVID-19 vaccine as part of Phase 1A. This includes staff and students working in the following areas: university health services, dentistry, nursing, social work, kinesiology, public health, pharmacy and others working in a clinical setting.

“There will be enough vaccine for everyone and we expect new deliveries every week,” reads the email.

Monday at 9 a.m. Michigan Medicine reported the following vaccine data:

• Number of total vaccine doses received by the University of Michigan: 11,950
• Number of vaccines administered to the UM community: 10,900
• Number of vaccines administered to the UM community on Sunday 3 January: 870
• Number of vaccinations currently scheduled for Monday 4 January and Tuesday 5 January: 1 594

With a new shipment of vaccines expected Tuesday, Michigan Medicine estimates it will plan the last of its current Phase 1A group by Jan. 12.

Michigan Medicine gives vaccines seven days a week. On Thursday, Michigan Stadium opened as a new vaccination site, which will play a central role in vaccinating tens of thousands of people as the health care system receives more doses of the vaccine.

Related reading: